nach oben

Reactions Weekly

Erschienen in:

01.08.2018 | Case report

Prednisolone

Steroid-induced ocular hypertension: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Prednisolone was referred to as prednisone at one instance in the article. However, according to the case presentation, it was considered as prednisolone.

Arai T, et al. Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases. Ocular Immunology and Inflammation 26: 779-782, No. 5, 2018. Available from: URL: http://doi.org/10.1080/09273948.2017.1278776 - JapanCrossRefPubMed

Titel: Prednisolone
Steroid-induced ocular hypertension: case report
Publikationsdatum: 01.08.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-50129-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prednisolone

Steroid-induced ocular hypertension: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Eltrombopag

Azathioprine/ciclosporin/prednisolone

Dexmedetomidine

Lurasidone

Propafenone overdose

Azithromycin